What is the price of Miravant Medical Technologies Inc. (MRVT)

The price of Miravant Medical Technologies Inc. (MRVT) is $0.00001

What is the market cap of Miravant Medical Technologies Inc. (MRVT)

The market cap of Miravant Medical Technologies Inc. (MRVT) is $352.62

Miravant Medical Technologies Inc. (MRVT) Price and Market Cap

Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light. Furthermore, the company manufactures the essential light-generating and light-delivery devices required for this treatment. Miravant's product pipeline includes several therapeutic agents: PHOTREX, which is aimed at treating wet age-related macular degeneration (AMD); MV9411, a photoreactive compound developed for managing plaque psoriasis; MV0633, which targets conditions like atherosclerosis, vulnerable atherosclerotic plaque, and restenosis; MV2101, designed to address vascular access graft disease in hemodialysis patients; and MV6401, a treatment under development for solid tumors. The organization, originally established as PDT, Inc., officially adopted its current name, Miravant Medical Technologies Inc., in September of 1997. Founded in 1989, it maintains its corporate headquarters in Santa Barbara, California.

Price of MRVT	Asset B	Mkt. of B	Results
$153,883 $352.62	NVDA	$5.426T	+1,538,825,340,750.91%
$125,520 $352.62	AAPL	$4.426T	+1,255,202,087,013.01%
$117,940 $352.62	GOOG	$4.159T	+1,179,396,053,988.24%
$103,869 $352.62	MSFT	$3.663T	+1,038,689,523,052.02%
$82,012.46 $352.62	AMZN	$2.892T	+820,124,595,902.65%

Price of MRVT

Asset B

Mkt. of B

Results

$153,883 $352.62